{"id":"W4255815021","doi":"10.1200/jco.2011.29.7_suppl.3","title":"A phase III randomized trial comparing intermittent versus continuous androgen suppression for patients with PSA progression after radical therapy: NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/UK Intercontinental Trial CRUKE/01/013.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Androgen deprivation therapy; Clinical endpoint; Prostate cancer; Interim analysis; Internal medicine; Randomized controlled trial; Goserelin; Androgen suppression; Prostatectomy; Urology; Placebo; Progression-free survival; Androgen; Oncology; Cancer; Chemotherapy; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004272749,0.0004057757,0.003996553,0.000261467,0.0001290313,0.00005034201,0.0003326508,0.0005335282,0.0004306938],"category_scores_gemma":[0.002381425,0.0002121658,0.001447896,0.0001315227,0.0009631072,0.0002335447,0.000149408,0.001253317,0.000006856948],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002767635,"about_ca_system_score_gemma":0.001323559,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001736697,"about_ca_topic_score_gemma":0.00001279565,"domain_scores_codex":[0.993219,0.001265805,0.003539567,0.0004888891,0.0008555576,0.0006312189],"domain_scores_gemma":[0.9933125,0.002520915,0.002376697,0.0003119101,0.0006939977,0.0007839708],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8660423,0.01888596,0.007365089,0.00003386528,0.001797577,0.0005488097,0.000579798,8.150223e-8,0.00003371992,0.000005281135,0.001458421,0.1032492],"study_design_scores_gemma":[0.8300812,0.1609655,0.001428894,0.0004579101,0.001039117,0.00004652243,0.0001147488,0.00008955519,0.0004216336,0.00004914797,0.005113284,0.0001924758],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9852321,0.0008464041,0.0002510961,0.000654899,0.005070106,0.007428478,0.00001433284,0.00002586153,0.000476691],"genre_scores_gemma":[0.9947279,0.0004292782,0.001620308,0.0002263553,0.002185168,0.0005148468,0.00006039714,0.0000504566,0.0001852959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1420795,"threshold_uncertainty_score":0.8651871,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1550202324802234,"score_gpt":0.4819053568972396,"score_spread":0.3268851244170162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}